Showing results (131-140 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 14, 2012
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospitalJosé González-Costello, Jonathan Yang, Daniel B Sims, et al.
Journal of Pharmaceutical Sciences|January 1, 1986
Stability of aspirin in solid mixturesD J Ager, K S Alexander, A S Bhatti, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 2, 2024
Intraoperative Epoprostenol in Type II Heparin-Induced Thrombocytopenia During Left-Ventricular Assist Device Implantation: A Case Series and Review of LiteratureAkhil Avunoori Chandra, Vidish Pandya, Luis Pina Martina, et al.
Circulation|January 7, 2020
Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart AssociationRobb D Kociol, Leslie T Cooper, James C Fang, et al.
Journal of Proteome Research|August 10, 2017
Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential BiomarkersDavid E Sleat, Abla Tannous, Istvan Sohar, et al.
Neuron|January 1, 1989
Monoamine oxidase deficiency in males with an X chromosome deletionK B Sims, A de la Chapelle, R Norio, et al.
Cancer Immunology Research|September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-TDouglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 2, 2012
SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experienceJeffrey A Brown, Jionghong Min, John F Staropoli, et al.
Clinical Genetics|March 4, 2008
Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort studyK B Sims, G M Pastores, N J Weinreb, et al.
Coronary Artery Disease|December 19, 2006
Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathyShawn A Gregory, Calum A MacRae, Kusai Aziz, et al.
Pageof 20